These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 32416187

  • 1. miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells.
    Shi X, Valizadeh A, Mir SM, Asemi Z, Karimian A, Majidina M, Safa A, Yosefi B.
    Eur J Pharmacol; 2020 Aug 05; 880():173138. PubMed ID: 32416187
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
    Shen H, Li L, Yang S, Wang D, Zhong S, Zhao J, Tang J.
    Gene; 2016 Nov 15; 593(1):84-90. PubMed ID: 27523474
    [Abstract] [Full Text] [Related]

  • 3. miR-21 inhibition reverses doxorubicin-resistance and inhibits PC3 human prostate cancer cells proliferation.
    Zhao W, Ning L, Wang L, Ouyang T, Qi L, Yang R, Wu Y.
    Andrologia; 2021 Jun 15; 53(5):e14016. PubMed ID: 33598946
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer.
    Xie M, Fu Z, Cao J, Liu Y, Wu J, Li Q, Chen Y.
    Biomed Pharmacother; 2018 Jun 15; 102():286-294. PubMed ID: 29567542
    [Abstract] [Full Text] [Related]

  • 6. Downregulation of miR-222-3p Reverses Doxorubicin-Resistance in LoVo Cells Through Upregulating Forkhead Box Protein P2 (FOXP2) Protein.
    Wang H, Deng Z, Chen X, Cai J, Ma T, Zhong Q, Li R, Li L, Li T.
    Med Sci Monit; 2019 Mar 24; 25():2169-2178. PubMed ID: 30904920
    [Abstract] [Full Text] [Related]

  • 7. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z, Yang N, Liang W, Yan X, Li L, Pan L.
    Leuk Lymphoma; 2012 Jul 24; 53(7):1383-9. PubMed ID: 22185283
    [Abstract] [Full Text] [Related]

  • 8. MiR-202-5p/PTEN mediates doxorubicin-resistance of breast cancer cells via PI3K/Akt signaling pathway.
    Liu T, Guo J, Zhang X.
    Cancer Biol Ther; 2019 Jul 24; 20(7):989-998. PubMed ID: 30983514
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation of miR-29a facilitates apoptosis of colorectal carcinoma cell SW480 and suppresses its Paclitaxel resistance.
    Yuan LL, Li L, Liu JN, Mei J, Lei CJ.
    Eur Rev Med Pharmacol Sci; 2018 Sep 24; 22(17):5499-5507. PubMed ID: 30229821
    [Abstract] [Full Text] [Related]

  • 10. miR-205 Reverses MDR-1 Mediated Doxorubicin Resistance via PTEN in Human Liver Cancer HepG2 Cells.
    Li M, Li ZH, Song J, Li X, Zhai P, Mu X, Qiu F, Yao L.
    Cell J; 2022 Mar 24; 24(3):112-119. PubMed ID: 35451580
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of tensin homolog deleted on chromosome ten (PTEN) by ciglitazone sensitizes doxorubicin-resistance leukemia cancer cells to treatment.
    Mashayekhi S, Yousefi B, Tohidi E, Darband SG, Mirza-Aghazadeh-Attari M, Sadighparvar S, Kaviani M, Shafiei-Irannejad V, Kafil HS, Karimian A, Jadidi-Niaragh F, Majidinia M.
    J Cell Biochem; 2019 Sep 24; 120(9):15719-15729. PubMed ID: 31087712
    [Abstract] [Full Text] [Related]

  • 12. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.
    Wang DD, Yang SJ, Chen X, Shen HY, Luo LJ, Zhang XH, Zhong SL, Zhao JH, Tang JH.
    Tumour Biol; 2016 Nov 24; 37(11):15315-15324. PubMed ID: 27699665
    [Abstract] [Full Text] [Related]

  • 13. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
    Shen H, Wang D, Li L, Yang S, Chen X, Zhou S, Zhong S, Zhao J, Tang J.
    Gene; 2017 Jan 05; 596():110-118. PubMed ID: 27746366
    [Abstract] [Full Text] [Related]

  • 14. Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin.
    Han GY, Cui JH, Liang S, Li HL.
    Eur Rev Med Pharmacol Sci; 2018 Nov 05; 22(22):7696-7703. PubMed ID: 30536312
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-221 Upregulates the Expression of P-gp and Bcl-2 by Activating the Stat3 Pathway to Promote Doxorubicin Resistance in Osteosarcoma Cells.
    Liu Y, Liu X, Yang S.
    Biol Pharm Bull; 2021 Jun 01; 44(6):861-868. PubMed ID: 33828027
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway.
    Tian T, Fu X, Lu J, Ruan Z, Nan K, Yao Y, Yang Y.
    J Biochem Mol Toxicol; 2018 Aug 01; 32(8):e22167. PubMed ID: 29968951
    [Abstract] [Full Text] [Related]

  • 17. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W, Lahouel M, Rouibah H, Zihlif M, Ahram M, Abu-Irmaileh B, Mustafa E, Al-Ameer HJ, Al Shhab M.
    Anticancer Agents Med Chem; 2018 Aug 01; 18(9):1330-1337. PubMed ID: 30088453
    [Abstract] [Full Text] [Related]

  • 18. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F, Liu S, He S, Xie Z, Zu X, Jiang Y.
    Oncol Rep; 2010 May 01; 23(5):1469-75. PubMed ID: 20372866
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway.
    Miao Y, Zheng W, Li N, Su Z, Zhao L, Zhou H, Jia L.
    Sci Rep; 2017 Feb 06; 7():41942. PubMed ID: 28165066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.